Abstract
Multidrug‐resistant CHRC5 cells were about 10‐fold more resistant to the proteinaceous anticancer drug neocarzinostatin (NCS) and its nonprotein chromophore (NPC) than the parental AUXB1 cells. There was little difference in cell growth, glutathione content, or activities of several antioxidant enzymes between the two cell lines. The degree of intracellular incorporation and extracellular excretion of fiuorescein isothiocyanate‐labeled NCS by CHRC5 cells was similar to that of AUXB1 cells. On the other hand, 20 μM verapamil or 27 μM cepharanthine restored the susceptibility of CHRC5 cells to NCS and NPC to the level of AUXB1 cells. In addition, NPC was found to suppress the photolabeling of [3H]azidopine (a known P‐glycoprotein‐binding ligand) to plasma membranes of CHHC5 cells. All these findings favor the possibility that NPC was excreted via P‐glycoprotein, which may contribute to the resistance of CHRC5 cells to NCS.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call